Clinical context

Cataract surgery outcomes are not defined by best-corrected visual acuity alone. Refractive accuracy, vision at different distances, spectacle dependence, contrast sensitivity, dysphotopsia and procedural safety all matter. Corneal and macular status, capsular support, cataract density and IOL calculation also shape the final result. A statistically convincing average therefore still has to be interpreted against the characteristics of an individual eye.

What was studied

The authors systematically searched for toric IOL studies with at least one year of follow-up in otherwise healthy eyes undergoing cataract surgery. PubMed and Ovid Embase were searched through 11 April 2025. Nineteen reports were included: 15 cohorts, three case series and one case report, covering 1,180 participants and 1,564 eyes. Primary outcomes were residual refractive astigmatism, IOL rotation and repositioning.

How the evidence was produced

A systematic review is valuable because it uses a transparent search and predefined criteria to assess the available literature. Reliability depends on search completeness, study selection, risk-of-bias assessment and the quality of included evidence. A broad review cannot remove limitations in the primary studies or turn heterogeneous evidence into a universal recommendation.

Key result Mean follow-up was 29.9 ± 23.7 months, ranging from 12 to 96 months. Mean residual cylinder was −0.65 ± 0.39 D at one year and −0.80 ± 0.54 D at two years. Mean IOL rotation was 2.27 ± 1.40° at one year and 2.82 ± 1.73° at two years. Twelve lenses, or 0.77% of studied eyes, required repositioning. The authors concluded that effective astigmatism reduction generally persisted for up to two years, while evidence beyond that interval remained limited.

How to interpret the result

The review supports long-term mechanical stability for most toric IOLs and a low frequency of reoperation. A mean residual cylinder, however, does not show the distribution of individual misses, and modest mean rotation does not exclude clinically important movement in one patient. The evidence can inform counseling and postoperative axis checks, but it cannot identify one platform as universally superior.

The result should be understood as an estimate for the population studied, not a promise of an individual outcome. Statistical and clinical significance, absolute and relative effects, and prespecified and exploratory analyses should be distinguished. When several endpoints or subgroups are reported, the prespecified primary endpoint for which the study was designed usually provides the most reliable inference.

Clinical applicability

This evidence is most useful as a basis for preoperative discussion and surgical planning. It helps identify which outcomes should be measured and which trade-offs should be explained to patients. The average effect should not be generalized to every IOL, technique or patient without checking eligibility criteria, surgeon experience, biometry, ocular comorbidity and duration of follow-up.

Limitations

The evidence was predominantly observational and heterogeneous, combining different IOL models, methods of measuring rotation, baseline astigmatism and follow-up schedules. Case series and a single case report are particularly vulnerable to selection and publication bias. Data beyond two years were sparse despite a maximum follow-up of 96 months. The source should be checked for its risk-of-bias assessment, model-specific results, the definition of repositioning and handling of patients lost to follow-up.

Beyond the limitations acknowledged by the authors, confidence is affected by sample size, follow-up duration, missing data, choice of comparator and relevance of the outcomes to routine care. Uncommon complications may remain undetected even in a well-conducted study. External validity is reduced when participants, equipment or investigator expertise differ substantially from everyday settings.

What to verify in the source

In the full paper, verify the protocol, eligibility criteria, baseline group characteristics, primary endpoint definition, confidence intervals, adverse events and losses to follow-up. Funding, conflicts of interest, trial registration and consistency between the published analysis and the original plan deserve separate attention. The DOI or source link below provides access to the primary publication for this check.